Support now

Your membership makes a difference

As OvaSupporter you contribute 50 DKK a year towards OvaCure’s work

OvaCure works to initiate research in the field of ovarian cancer. We do this by bringing together leading researchers from all over the world and facilitating workshops and networks to initiate new research projects. Since 2014, OvaCure has initiated and supported 13 research projects.

Ovarian cancer is the most deadly gynecological cancer, and yet it is a disease about which we still lack knowledge. This means that the survival rate among the affected women is very low, and many women experience ineffective or few treatment options.

By increasing research, we can learn how to detect it earlier, find better treatment options, and ultimately a cure so that no women have to fear dying of ovarian cancer.

How it works

It costs 50 DKK a year to be a member of OvaCure. The membership fee is not tax deductible. This means that we deduct 50 DKK from the total amount you donate per year before we declare the amount to the tax authority. The more you donate, the larger your deduction will be.

It is the same principle with a single or one-time donation. For example, if you donate 600 DKK and say yes to a membership, you will receive a deduction for the 550 DKK.

Remember to tick the box “Do you want tax deduction?” when filling in your information in the donation form.

What does it mean to be an OvaSupporter?

To be a fundraising organization requires 300 members.
That is exactly why your membership is crucial to OvaCure’s existence.

As an OvaSupporter, you will receive approximately four newsletters a year. You will be invited to special events, as well as OvaCure’s annual general assembly meeting. You can always unsubscribe from the newsletters but continue your membership.

Membership is valid for one year at a time and is automatically renewed if you are a regular contributor.
If you wish to unsubscribe from your membership, you can write to

“Far too many women die of ovarian cancer. Research is essential to find the best treatment and help the affected women in the best possible way.

Mansoor Raza Mirza
Chief Oncologist, Rigshospitalet